{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"4.661","value":"6.09"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"15"}],"units":"Participants"}],"description":"Duration of treatment is defined as the last dose date minus the first dose date of the dose cohort plus 1 expressed in weeks.","dispersionType":"Standard Deviation","groups":[{"description":"Twice-weekly dosing with 2-hour IV infusions on days 1,4,8, and 11 of 3-week cycles","id":"OG000","title":"MRZ 0.5 mg/m^2"}],"paramType":"MEAN","reportingStatus":"POSTED","timeFrame":"Through study completion, an average of 6.09 weeks.","title":"Duration of MRZ Treatment","type":"SECONDARY","unitOfMeasure":"weeks"}